2-[2-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-phenyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]ethyl]pyridine-3-carboxylic acid;2-[3-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-phenyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]propyl]pyridine-3-carboxylic acid;2-[3-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-[(E)-2-phenylethenyl]-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-6-yl]propyl]pyridine-3-carboxylic acid

C86H89N21O17 — CID 160969283

IUPAC2-[2-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-phenyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]ethyl]pyridine-3-carboxylic acid;2-[3-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-phenyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]propyl]pyridine-3-carboxylic acid;2-[3-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-[(E)-2-phenylethenyl]-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-6-yl]propyl]pyridine-3-carboxylic acid
SMILESCCNC(=O)Nc1ncnc2c1ncn2C1CC(CCCc2ncccc2C(=O)O)C2O[C@H](/C=C/c3ccccc3)OC21.CCNC(=O)Nc1ncnc2c1ncn2C1OC(CCCc2ncccc2C(=O)O)C2O[C@H](c3ccccc3)OC21.CCNC(=O)Nc1ncnc2c1ncn2C1OC(CCc2ncccc2C(=O)O)C2O[C@H](c3ccccc3)OC21
InChIInChI=1S/C31H33N7O5.C28H29N7O6.C27H27N7O6/c1-2-32-31(41)37-28-25-29(35-17-34-28)38(18-36-25)23-16-20(10-6-12-22-21(30(39)40)11-7-15-33-22)26-27(23)43-24(42-26)14-13-19-8-4-3-5-9-19;1-2-29-28(38)34-23-20-24(32-14-31-23)35(15-33-20)25-22-21(40-27(41-22)16-8-4-3-5-9-16)19(39-25)12-6-11-18-17(26(36)37)10-7-13-30-18;1-2-28-27(37)33-22-19-23(31-13-30-22)34(14-32-19)24-21-20(39-26(40-21)15-7-4-3-5-8-15)18(38-24)11-10-17-16(25(35)36)9-6-12-29-17/h3-5,7-9,11,13-15,17-18,20,23-24,26-27H,2,6,10,12,16H2,1H3,(H,39,40)(H2,32,34,35,37,41);3-5,7-10,13-15,19,21-22,25,27H,2,6,11-12H2,1H3,(H,36,37)(H2,29,31,32,34,38);3-9,12-14,18,20-21,24,26H,2,10-11H2,1H3,(H,35,36)(H2,28,30,31,33,37)/b14-13+;;/t20?,23?,24-,26?,27?;19?,21?,22?,25?,27-;18?,20?,21?,24?,26-/m000/s1
InChIKeySYAWRMGDFNRWKY-SCURGJCMSA-N
MW1688.79 g/mol
LogP11.01
Rot. Bonds27

About 2-[2-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-phenyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]ethyl]pyridine-3-carboxylic acid;2-[3-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-phenyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]propyl]pyridine-3-carboxylic acid;2-[3-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-[(E)-2-phenylethenyl]-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-6-yl]propyl]pyridine-3-carboxylic acid

2-[2-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-phenyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]ethyl]pyridine-3-carboxylic acid;2-[3-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-phenyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]propyl]pyridine-3-carboxylic acid;2-[3-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-[(E)-2-phenylethenyl]-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-6-yl]propyl]pyridine-3-carboxylic acid (PubChem CID 160969283) has the molecular formula C86H89N21O17 and a molecular weight of 1688.79 g/mol. Its IUPAC name is 2-[2-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-phenyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]ethyl]pyridine-3-carboxylic acid;2-[3-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-phenyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]propyl]pyridine-3-carboxylic acid;2-[3-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-[(E)-2-phenylethenyl]-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-6-yl]propyl]pyridine-3-carboxylic acid.

Molecular Properties

Compound Name2-[2-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-phenyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]ethyl]pyridine-3-carboxylic acid;2-[3-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-phenyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]propyl]pyridine-3-carboxylic acid;2-[3-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-[(E)-2-phenylethenyl]-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-6-yl]propyl]pyridine-3-carboxylic acid
PubChem CID160969283
Molecular FormulaC86H89N21O17
Molecular Weight1688.79 g/mol
Exact Mass1687.67
IUPAC Name2-[2-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-phenyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]ethyl]pyridine-3-carboxylic acid;2-[3-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-phenyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]propyl]pyridine-3-carboxylic acid;2-[3-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-[(E)-2-phenylethenyl]-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-6-yl]propyl]pyridine-3-carboxylic acid
SMILESCCNC(=O)Nc1ncnc2c1ncn2C1CC(CCCc2ncccc2C(=O)O)C2O[C@H](/C=C/c3ccccc3)OC21.CCNC(=O)Nc1ncnc2c1ncn2C1OC(CCCc2ncccc2C(=O)O)C2O[C@H](c3ccccc3)OC21.CCNC(=O)Nc1ncnc2c1ncn2C1OC(CCc2ncccc2C(=O)O)C2O[C@H](c3ccccc3)OC21
InChIInChI=1S/C31H33N7O5.C28H29N7O6.C27H27N7O6/c1-2-32-31(41)37-28-25-29(35-17-34-28)38(18-36-25)23-16-20(10-6-12-22-21(30(39)40)11-7-15-33-22)26-27(23)43-24(42-26)14-13-19-8-4-3-5-9-19;1-2-29-28(38)34-23-20-24(32-14-31-23)35(15-33-20)25-22-21(40-27(41-22)16-8-4-3-5-9-16)19(39-25)12-6-11-18-17(26(36)37)10-7-13-30-18;1-2-28-27(37)33-22-19-23(31-13-30-22)34(14-32-19)24-21-20(39-26(40-21)15-7-4-3-5-8-15)18(38-24)11-10-17-16(25(35)36)9-6-12-29-17/h3-5,7-9,11,13-15,17-18,20,23-24,26-27H,2,6,10,12,16H2,1H3,(H,39,40)(H2,32,34,35,37,41);3-5,7-10,13-15,19,21-22,25,27H,2,6,11-12H2,1H3,(H,36,37)(H2,29,31,32,34,38);3-9,12-14,18,20-21,24,26H,2,10-11H2,1H3,(H,35,36)(H2,28,30,31,33,37)/b14-13+;;/t20?,23?,24-,26?,27?;19?,21?,22?,25?,27-;18?,20?,21?,24?,26-/m000/s1
InChIKeySYAWRMGDFNRWKY-SCURGJCMSA-N
XLogP11.01
TPSA478.60 Ų
H-Bond Donors9
H-Bond Acceptors29
Rotatable Bonds27
Heavy Atoms124
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001688.79
LogP ≤ 511.01
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1029

Analyze 2-[2-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-phenyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]ethyl]pyridine-3-carboxylic acid;2-[3-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-phenyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]propyl]pyridine-3-carboxylic acid;2-[3-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-[(E)-2-phenylethenyl]-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-6-yl]propyl]pyridine-3-carboxylic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[2-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-phenyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]ethyl]pyridine-3-carboxylic acid;2-[3-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-phenyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]propyl]pyridine-3-carboxylic acid;2-[3-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-[(E)-2-phenylethenyl]-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-6-yl]propyl]pyridine-3-carboxylic acid?
The IUPAC name of 2-[2-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-phenyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]ethyl]pyridine-3-carboxylic acid;2-[3-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-phenyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]propyl]pyridine-3-carboxylic acid;2-[3-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-[(E)-2-phenylethenyl]-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-6-yl]propyl]pyridine-3-carboxylic acid (CID 160969283) is 2-[2-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-phenyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]ethyl]pyridine-3-carboxylic acid;2-[3-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-phenyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]propyl]pyridine-3-carboxylic acid;2-[3-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-[(E)-2-phenylethenyl]-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-6-yl]propyl]pyridine-3-carboxylic acid.
What is the SMILES notation for 2-[2-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-phenyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]ethyl]pyridine-3-carboxylic acid;2-[3-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-phenyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]propyl]pyridine-3-carboxylic acid;2-[3-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-[(E)-2-phenylethenyl]-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-6-yl]propyl]pyridine-3-carboxylic acid?
The canonical SMILES for 2-[2-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-phenyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]ethyl]pyridine-3-carboxylic acid;2-[3-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-phenyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]propyl]pyridine-3-carboxylic acid;2-[3-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-[(E)-2-phenylethenyl]-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-6-yl]propyl]pyridine-3-carboxylic acid is CCNC(=O)Nc1ncnc2c1ncn2C1CC(CCCc2ncccc2C(=O)O)C2O[C@H](/C=C/c3ccccc3)OC21.CCNC(=O)Nc1ncnc2c1ncn2C1OC(CCCc2ncccc2C(=O)O)C2O[C@H](c3ccccc3)OC21.CCNC(=O)Nc1ncnc2c1ncn2C1OC(CCc2ncccc2C(=O)O)C2O[C@H](c3ccccc3)OC21.
What is the InChIKey of 2-[2-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-phenyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]ethyl]pyridine-3-carboxylic acid;2-[3-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-phenyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]propyl]pyridine-3-carboxylic acid;2-[3-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-[(E)-2-phenylethenyl]-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-6-yl]propyl]pyridine-3-carboxylic acid?
The InChIKey is SYAWRMGDFNRWKY-SCURGJCMSA-N. The full InChI is InChI=1S/C31H33N7O5.C28H29N7O6.C27H27N7O6/c1-2-32-31(41)37-28-25-29(35-17-34-28)38(18-36-25)23-16-20(10-6-12-22-21(30(39)40)11-7-15-33-22)26-27(23)43-24(42-26)14-13-19-8-4-3-5-9-19;1-2-29-28(38)34-23-20-24(32-14-31-23)35(15-33-20)25-22-21(40-27(41-22)16-8-4-3-5-9-16)19(39-25)12-6-11-18-17(26(36)37)10-7-13-30-18;1-2-28-27(37)33-22-19-23(31-13-30-22)34(14-32-19)24-21-20(39-26(40-21)15-7-4-3-5-8-15)18(38-24)11-10-17-16(25(35)36)9-6-12-29-17/h3-5,7-9,11,13-15,17-18,20,23-24,26-27H,2,6,10,12,16H2,1H3,(H,39,40)(H2,32,34,35,37,41);3-5,7-10,13-15,19,21-22,25,27H,2,6,11-12H2,1H3,(H,36,37)(H2,29,31,32,34,38);3-9,12-14,18,20-21,24,26H,2,10-11H2,1H3,(H,35,36)(H2,28,30,31,33,37)/b14-13+;;/t20?,23?,24-,26?,27?;19?,21?,22?,25?,27-;18?,20?,21?,24?,26-/m000/s1.
What are the key properties of 2-[2-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-phenyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]ethyl]pyridine-3-carboxylic acid;2-[3-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-phenyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]propyl]pyridine-3-carboxylic acid;2-[3-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-[(E)-2-phenylethenyl]-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-6-yl]propyl]pyridine-3-carboxylic acid?
2-[2-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-phenyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]ethyl]pyridine-3-carboxylic acid;2-[3-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-phenyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]propyl]pyridine-3-carboxylic acid;2-[3-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-[(E)-2-phenylethenyl]-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-6-yl]propyl]pyridine-3-carboxylic acid has a molecular weight of 1688.79 g/mol, XLogP of 11.01, 27 rotatable bonds, 9 hydrogen bond donors, and 29 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[2-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-phenyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]ethyl]pyridine-3-carboxylic acid;2-[3-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-phenyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]propyl]pyridine-3-carboxylic acid;2-[3-[(2S)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-[(E)-2-phenylethenyl]-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-6-yl]propyl]pyridine-3-carboxylic acid is sourced from PubChem (CID 160969283), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).